NewsEvents

Your Yourlocation: Home > Clinical observation of tiotropium bromide(136310-93-5) combined with sulpiride in the treatment of COPD

To investigate the clinical efficacy of tiotropium bromide(136310-93-5) combined with sulpiride in the treatment of chronic obstructive pulmonary disease (COPD). Methods: Sixty patients with COPD were randomly divided into observation group and control group. The control group was treated with sulindole alone. The observation group was treated with tiotropium bromide and sulinda treatment. The forced expiratory volume (FEV1) (FEV1 / FVC), arterial oxygen partial pressure (PO2), partial pressure of carbon dioxide (PCO2) and clinical symptom score of the first forced expiratory volume. Results: The efficacy of FEV1, FEV1 / FVC, PO2, PCO2 and clinical symptoms were significantly higher in patients with COPD than tiotropium bromide(136310-93-5) combined with sulpiride, and the difference was significant (P <0.05). Conclusion: Treatment of COPD with tiotropium combined with sulpiride can improve the lung function and quality of life in patients, and it is worthy to be popularized.

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved